[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572135":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":31,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":7,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":52,"overallStatus":56,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Ping Fei, MD","CONTACT","86+15000672472","shirleypingfei@126.com",[15],{"facility":16,"status":7,"city":17,"state":7,"zip":18,"country":19,"countryCode":20,"cosmosGeoPoint":21,"geoPoint":26,"contacts":27},"Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","Shanghai","200092","China","CN",{"type":22,"coordinates":23},"Point",[24,25],121.45806,31.22222,{"lat":25,"lon":24},[28,29],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":30,"role":11,"phone":7,"phoneExt":7,"email":7},"Peiquan Zhao, PhD",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Peiquan Zhao","Director of the Department of Ophthalmology","100572135","a-multicenter-and-prospective-study-of-screening-retinopathy-of-prematurity-in-china-100572135",false,"NCT06729333","A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China","SChiROP","Inclusion Criteria:\n\nFrom December 2024 to May 2025, preterm infants (gestational age \\\u003C37 weeks) or low birth weight infants (birth weight \\\u003C2500 g) who receive their first ROP screening at Xinhua Hospital or partner institutions will be included.\n\nExclusion Criteria:\n\n1. Death before the first screening;\n2. Death or loss to follow-up before complete retinal vascularization;\n3. Presence of other diseases causing incomplete retinal vascularization, such as familial exudative vitreoretinopathy, incontinentia pigmenti, or Coats disease;\n4. Coexisting conditions affecting the classification or staging of ROP, such as corneal opacity, congenital cataract, persistent fetal vasculature, retinoblastoma, anophthalmia, Terson syndrome, or other ocular infections or diseases;\n5. Poor systemic condition preventing fundus examination;\n6. History of ocular trauma or surgery (excluding treatments for ROP);\n7. Poor-quality fundus images;\n8. Other conditions deemed exclusionary by the investigators.","ALL",{"count":44,"type":45},5000,"ESTIMATED","OBSERVATIONAL","The purpose of the study is to explore the current incidence rate of retinopathy of prematurity (ROP) in China and to explore more appropriate screening criteria for ROP.",[49,50,51],"Premature Birth of Newborn","Retinopathy of Prematurity (ROP)","Low Birthweight Infant",[53,54,55],"retinopathy of prematurity","incidence rate","screening","NOT_YET_RECRUITING","2024-12-06",{"date":59,"type":60},"2024-12-11","ACTUAL",{"date":62,"type":45},"2024-12-15",{"date":64,"type":45},"2026-06-14",{"name":5,"class":6},1]